Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment

Ayako Shimada, Takahiro Tsushima, Yasuhiro Tsubosa, Eisuke Booka, Katsushi Takebayashi, Masahiro Niihara, Mitsuhiro Isaka, Yasuhisa Ohde, Nozomu Machida, Yusuke Onozawa, Hirofumi Yasui, Hiroya Takeuchi, Yuukou Kitagawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Despite the poor prognosis of recurrent esophageal squamous cell cancer (ESCC), long-term survival could be achieved in a subset of patients who successfully underwent surgical resection for recurrence. In this study, we investigated the outcomes of surgical resection for lymph node (LN) or pulmonary (PUL) recurrence in ESCC patients. Methods: We retrospectively analyzed the outcomes of ESCC patients who underwent surgical resection between January 2008 and March 2015 for either LN or PUL recurrence after complete response (CR) by chemoradiotherapy or R0 esophagectomy. Every patient fulfilled the original institutional criteria: no recurrence at primary site; recurrence involving in only one organ; expectation of complete resection; and for PUL recurrence, no rapid growth with at least 2 months of observation. Results: Among the 13 patients analyzed, surgical resection was performed in nine and four patients with LN and PUL recurrence, respectively. R0 resection was achieved in all patients with no fatal surgical complications. Mean duration from the day of the first CR/R0 to the recurrence was 809 (110–2575) days. Median recurrence-free survival following surgical resection for recurrence and overall survival following the first diagnosis of recurrence was 387 and 1297 days, respectively. Conclusion: Surgical resection for LN or PUL recurrence of ESCC according to our institutional criteria can be performed safely for selected patients.

Original languageEnglish
Pages (from-to)1286-1293
Number of pages8
JournalWorld Journal of Surgery
Volume43
Issue number5
DOIs
Publication statusPublished - 2019 May 15

Fingerprint

Esophageal Neoplasms
Lymph Nodes
Recurrence
Lung
Squamous Cell Neoplasms
Therapeutics
Survival
Esophagectomy
Chemoradiotherapy
Observation

ASJC Scopus subject areas

  • Surgery

Cite this

Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment. / Shimada, Ayako; Tsushima, Takahiro; Tsubosa, Yasuhiro; Booka, Eisuke; Takebayashi, Katsushi; Niihara, Masahiro; Isaka, Mitsuhiro; Ohde, Yasuhisa; Machida, Nozomu; Onozawa, Yusuke; Yasui, Hirofumi; Takeuchi, Hiroya; Kitagawa, Yuukou.

In: World Journal of Surgery, Vol. 43, No. 5, 15.05.2019, p. 1286-1293.

Research output: Contribution to journalArticle

Shimada, A, Tsushima, T, Tsubosa, Y, Booka, E, Takebayashi, K, Niihara, M, Isaka, M, Ohde, Y, Machida, N, Onozawa, Y, Yasui, H, Takeuchi, H & Kitagawa, Y 2019, 'Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment', World Journal of Surgery, vol. 43, no. 5, pp. 1286-1293. https://doi.org/10.1007/s00268-018-04904-w
Shimada, Ayako ; Tsushima, Takahiro ; Tsubosa, Yasuhiro ; Booka, Eisuke ; Takebayashi, Katsushi ; Niihara, Masahiro ; Isaka, Mitsuhiro ; Ohde, Yasuhisa ; Machida, Nozomu ; Onozawa, Yusuke ; Yasui, Hirofumi ; Takeuchi, Hiroya ; Kitagawa, Yuukou. / Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment. In: World Journal of Surgery. 2019 ; Vol. 43, No. 5. pp. 1286-1293.
@article{c60a64a1ddd84f919f439edce981e05b,
title = "Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment",
abstract = "Background: Despite the poor prognosis of recurrent esophageal squamous cell cancer (ESCC), long-term survival could be achieved in a subset of patients who successfully underwent surgical resection for recurrence. In this study, we investigated the outcomes of surgical resection for lymph node (LN) or pulmonary (PUL) recurrence in ESCC patients. Methods: We retrospectively analyzed the outcomes of ESCC patients who underwent surgical resection between January 2008 and March 2015 for either LN or PUL recurrence after complete response (CR) by chemoradiotherapy or R0 esophagectomy. Every patient fulfilled the original institutional criteria: no recurrence at primary site; recurrence involving in only one organ; expectation of complete resection; and for PUL recurrence, no rapid growth with at least 2 months of observation. Results: Among the 13 patients analyzed, surgical resection was performed in nine and four patients with LN and PUL recurrence, respectively. R0 resection was achieved in all patients with no fatal surgical complications. Mean duration from the day of the first CR/R0 to the recurrence was 809 (110–2575) days. Median recurrence-free survival following surgical resection for recurrence and overall survival following the first diagnosis of recurrence was 387 and 1297 days, respectively. Conclusion: Surgical resection for LN or PUL recurrence of ESCC according to our institutional criteria can be performed safely for selected patients.",
author = "Ayako Shimada and Takahiro Tsushima and Yasuhiro Tsubosa and Eisuke Booka and Katsushi Takebayashi and Masahiro Niihara and Mitsuhiro Isaka and Yasuhisa Ohde and Nozomu Machida and Yusuke Onozawa and Hirofumi Yasui and Hiroya Takeuchi and Yuukou Kitagawa",
year = "2019",
month = "5",
day = "15",
doi = "10.1007/s00268-018-04904-w",
language = "English",
volume = "43",
pages = "1286--1293",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment

AU - Shimada, Ayako

AU - Tsushima, Takahiro

AU - Tsubosa, Yasuhiro

AU - Booka, Eisuke

AU - Takebayashi, Katsushi

AU - Niihara, Masahiro

AU - Isaka, Mitsuhiro

AU - Ohde, Yasuhisa

AU - Machida, Nozomu

AU - Onozawa, Yusuke

AU - Yasui, Hirofumi

AU - Takeuchi, Hiroya

AU - Kitagawa, Yuukou

PY - 2019/5/15

Y1 - 2019/5/15

N2 - Background: Despite the poor prognosis of recurrent esophageal squamous cell cancer (ESCC), long-term survival could be achieved in a subset of patients who successfully underwent surgical resection for recurrence. In this study, we investigated the outcomes of surgical resection for lymph node (LN) or pulmonary (PUL) recurrence in ESCC patients. Methods: We retrospectively analyzed the outcomes of ESCC patients who underwent surgical resection between January 2008 and March 2015 for either LN or PUL recurrence after complete response (CR) by chemoradiotherapy or R0 esophagectomy. Every patient fulfilled the original institutional criteria: no recurrence at primary site; recurrence involving in only one organ; expectation of complete resection; and for PUL recurrence, no rapid growth with at least 2 months of observation. Results: Among the 13 patients analyzed, surgical resection was performed in nine and four patients with LN and PUL recurrence, respectively. R0 resection was achieved in all patients with no fatal surgical complications. Mean duration from the day of the first CR/R0 to the recurrence was 809 (110–2575) days. Median recurrence-free survival following surgical resection for recurrence and overall survival following the first diagnosis of recurrence was 387 and 1297 days, respectively. Conclusion: Surgical resection for LN or PUL recurrence of ESCC according to our institutional criteria can be performed safely for selected patients.

AB - Background: Despite the poor prognosis of recurrent esophageal squamous cell cancer (ESCC), long-term survival could be achieved in a subset of patients who successfully underwent surgical resection for recurrence. In this study, we investigated the outcomes of surgical resection for lymph node (LN) or pulmonary (PUL) recurrence in ESCC patients. Methods: We retrospectively analyzed the outcomes of ESCC patients who underwent surgical resection between January 2008 and March 2015 for either LN or PUL recurrence after complete response (CR) by chemoradiotherapy or R0 esophagectomy. Every patient fulfilled the original institutional criteria: no recurrence at primary site; recurrence involving in only one organ; expectation of complete resection; and for PUL recurrence, no rapid growth with at least 2 months of observation. Results: Among the 13 patients analyzed, surgical resection was performed in nine and four patients with LN and PUL recurrence, respectively. R0 resection was achieved in all patients with no fatal surgical complications. Mean duration from the day of the first CR/R0 to the recurrence was 809 (110–2575) days. Median recurrence-free survival following surgical resection for recurrence and overall survival following the first diagnosis of recurrence was 387 and 1297 days, respectively. Conclusion: Surgical resection for LN or PUL recurrence of ESCC according to our institutional criteria can be performed safely for selected patients.

UR - http://www.scopus.com/inward/record.url?scp=85060579862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060579862&partnerID=8YFLogxK

U2 - 10.1007/s00268-018-04904-w

DO - 10.1007/s00268-018-04904-w

M3 - Article

C2 - 30675631

AN - SCOPUS:85060579862

VL - 43

SP - 1286

EP - 1293

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

IS - 5

ER -